We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-13.49%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$42.1B
AUM Growth
-$7.13B
Cap. Flow
+$617M
Cap. Flow %
1.47%
Top 10 Hldgs %
24.6%
Holding
2,253
New
45
Increased
584
Reduced
402
Closed
95

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$209M
2
T icon
AT&T
T
+$156M
3
XOM icon
ExxonMobil
XOM
+$122M
4
JNJ icon
Johnson & Johnson
JNJ
+$84.2M
5
WMT icon
Walmart Inc
WMT
+$77.1M

Sector Composition

Rank Sector Weight
1 Technology 20.42%
2 Healthcare 18.92%
3 Financials 13.22%
4 Consumer Discretionary 8.69%
5 Industrials 7.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VUZI icon
1976
Vuzix
VUZI
$190M
$92K ﹤0.01%
12,990
OSCR icon
1977
Oscar Health
OSCR
$8.5B
$91K ﹤0.01%
21,460
PING
1978
DELISTED
Ping Identity Holding Corp.
PING
$91K ﹤0.01%
4,990
+2,760
+124% +$61.4K
AMR icon
1979
Alpha Metallurgical Resources
AMR
$1.82B
$90K ﹤0.01%
700
AZEK
1980
DELISTED
The AZEK Co
AZEK
$90K ﹤0.01%
5,380
DGII icon
1981
Digi International
DGII
$2.52B
$90K ﹤0.01%
3,700
RIVN icon
1982
Rivian
RIVN
$22.9B
$90K ﹤0.01%
3,500
+600
+21% +$18.7K
RAPT
1983
DELISTED
RAPT Therapeutics
RAPT
$88K ﹤0.01%
601
UEIC icon
1984
Universal Electronics
UEIC
$57.2M
$88K ﹤0.01%
3,451
BVN icon
1985
Compañía de Minas Buenaventura
BVN
$7.85B
$87K ﹤0.01%
13,150
TWOU
1986
DELISTED
2U Inc
TWOU
$87K ﹤0.01%
276
PNT
1987
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$86K ﹤0.01%
12,580
CWK icon
1988
Cushman & Wakefield Ltd
CWK
$2.98B
$85K ﹤0.01%
5,580
GWH icon
1989
ESS Tech
GWH
$22.1M
$85K ﹤0.01%
+2,015
New +$141K
FULC icon
1990
Fulcrum Therapeutics
FULC
$248M
$84K ﹤0.01%
17,200
IQ icon
1991
iQIYI
IQ
$1.18B
$84K ﹤0.01%
20,100
OLO
1992
DELISTED
Olo Inc
OLO
$84K ﹤0.01%
8,520
PTGX icon
1993
Protagonist Therapeutics
PTGX
$8.75B
$84K ﹤0.01%
10,680
EPIX
1994
DELISTED
ESSA Pharma
EPIX
$83K ﹤0.01%
26,282
-63,166
-71% -$353K
ZYME icon
1995
Zymeworks
ZYME
$1.68B
$83K ﹤0.01%
15,620
+7,350
+89% +$44.4K
RAD
1996
DELISTED
Rite Aid Corporation
RAD
$83K ﹤0.01%
12,270
OSUR icon
1997
OraSure Technologies
OSUR
$273M
$82K ﹤0.01%
30,318
SFIX
1998
Stitch Fix
SFIX
$478M
$82K ﹤0.01%
16,510
FORR icon
1999
Forrester Research
FORR
$172M
$81K ﹤0.01%
1,700
MMI icon
2000
Marcus & Millichap
MMI
$1.15B
$81K ﹤0.01%
2,200

Similar funds

Ensign Peak Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Ensign Peak Advisors held 2,253 positions worth $42.1B, down 14% from $49.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q2 2022 filing shows 45 new, 584 increased, 402 reduced and 95 closed positions. Its largest new stake was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M. The largest sale was iShares Russell 2000 ETF, an estimated $209M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q2 2022 buy was State Street Utilities Select Sector SPDR ETF: 455,528 shares worth $16M.
  • Ensign Peak Advisors added most to Merck in Q2 2022, an estimated $209M increase.
  • Ensign Peak Advisors's biggest Q2 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $209M.
  • Ensign Peak Advisors fully exited VMware, Inc in Q2 2022, selling an estimated $20.8M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $42.1B portfolio in Q2 2022.
  • Ensign Peak Advisors opened 45 new positions and closed 95 in Q2 2022.
  • Ensign Peak Advisors's portfolio value fell 14% quarter-over-quarter to $42.1B.

Based on Ensign Peak Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.